Table 1: % EWL and change in glycemic parameters (mg/dL) and blood pressure (mmHg) from baseline over 12 months.

ParameterTime following device activation—change from baseline value
Baseline1 week4 weeks12 weeks6 months 12 months

EWL %, <.0001
HbA1c (%),
FPG (mg/dL),
MAP, all subjects (mmHg),
SBP, all subjects (mmHg),
DBP, all subjects (mmHg),
MAP elevated (mmHg),
SBP elevated (mmHg),
DBP elevated (mmHg),

At 1, 4, and 12 weeks and 6 months; at 4 weeks, 12 weeks and 6 months; at 1 week, 12 weeks and 6 months; *at 12 weeks.
FPG: fasting plasma glucose, MAP: mean arterial pressure, SBP: systolic blood pressure, and DBP: diastolic blood pressure.